Abstract
The principal aim of this chapter is to evaluate the urodynamic and clinical outcomes at 6 months follow-up in men with or without significant IPP ( > 5 mm) undergoing HoLEP for BOO. Eight-four patients underwent HoLEP between January 2018 and December 2021. Inclusion criteria: men aged 50–75 years with prostate size from 30 to 100 grams, peak urinary flow rate less than 15 ml/s, and a diagnosis of BOO. At 6-month follow-up, urodynamics data show a statistically significant reduction in PdetOpen and PdetQmax compared with baseline in both IPP and no IPP groups. Statistically significant differences were found in maximal urodynamic bladder capacity before and after the operations in both groups as also IPSS data, Qmax, Qave, PVR and IPSS total score at 6 months when compared with preoperative data. HoLEP is efficient in improving functional outcomes and obstructive symptoms regardless of the presence of IPP. Surgeons can expect better postoperative outcomes in terms of Qmax, Qave and IPSS total score in patients with significant IPP.